I have four children currently in District 203. They are in fourth, sixth, ninth, and 10th grades. I have a unique ...

Marlise R. Luskin, MD, MSCE, discussed treatment options for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and ...

The FDA called for a clinical hold on the two phase 1 trials of UCART123, in acute myeloid leukaemia, and in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Cellectis said it is working with ...

Privately-held Menarini is paying up to $677 million for Stemline and Elzonris (tagraxofusp-erzs), the biotech’s treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN), which was ...